Study analysis · Scientific Reports · 2019
This Starch Shrinks Belly Fat in Just 4 Weeks — Without Weight Loss!
A special kind of fiber called resistant starch can reduce deep belly fat and improve blood sugar control, even in people at a healthy weight.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
这项研究就像一场公平的比赛，志愿者被随机分成两组，一组吃一种特别的淀粉，另一组吃普通淀粉，然后交换，大家不知道自己在哪组。结果发现这种淀粉确实可能让肚子上的脂肪减少，还能帮助身体分泌一些有用的激素。但参加的人很少，只有19个，所以我们要小心，不能肯定它对所有人都有效。
What’s the bottom line?
Scientists wanted to see if eating a type of starch that isn't digested could reduce belly fat in healthy people. They gave some people this special starch and others a regular starch, and measured their belly fat with a scanner.
How strong is this study?
这个研究做得挺仔细的，就像做实验时把其他条件都控制住，只改变我们要测试的东西。他们用双盲方法，大家都不知情，还交换着吃，这样结果更可靠。但因为人少，时间短，所以还不能说100%准确，但已经比很多研究要严谨了。
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
77 / 100
- Randomization+20/20
- Blinding+15/15
- Control group+15/15
- Sample size (n=19)+1.8/20
- Follow-up+10/10
100 / 100
100 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 580 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
This design can establish causation. 虽然该研究是随机双盲交叉试验，可以建立因果关系，但样本量较小（19名受试者）且为单一中心，结果可能不具有普遍性。此外，研究的持续时间较短（4周），长期效应未知。
COI Unknown
Could not determine conflict of interest status
No conflicts of interest information is provided in the available text.
Independent Analysis Safeguards
- Randomized double-blinded crossover design
- Controlled diet
The provided text does not include conflict of interest or funding declarations. The study is a randomized, double-blinded crossover trial with a controlled diet, which helps minimize bias. However, without additional information, it is impossible to assess potential conflicts of interest or funding sources.
Key takeaways
- 01
After 4 weeks of eating 40 grams of the special starch each day, the fat around the belly (especially the deep fat and fat under the skin) was reduced.
- 02
It also increased some helpful hormones and changed the gut bacteria.
- 03
This means that adding this special starch to your diet might help reduce belly fat, but it was tested in only 19 healthy adults, so more research is needed to see if it works for everyone.
Surprising findings
- Resistant starch reduced visceral fat in normal-weight adults, something not seen in obese/overweight populations in earlier studies.Most research on RS for obesity has been in rodents or overweight humans. This is the first human trial to show a fat-reducing effect specifically in people at a healthy weight.
- Despite improved early insulin secretion, insulin sensitivity (measured by clamp) didn't change.Insulin sensitivity improvements are often expected with metabolic benefits, but here the effect was on secretion, not sensitivity.
- High baseline Streptococcus was good for response, but Streptococcus is typically associated with obesity.Streptococcus is often considered a harmful bacterium, but here it predicted better hormonal responses to RS.
Practical takeaways
Add resistant starch to your diet gradually. Good sources: cooked and cooled potatoes, green bananas, legumes, and raw oats. Aim for 15-30g/day initially.
The study used 40g/day, which is higher than typical intake. Start slow to avoid GI distress.
medium confidencePair resistant starch with probiotics/fermented foods to support gut bacteria.
Microbiome effects vary; not a substitute for overall healthy diet.
low confidenceIf you're diabetes-prone, resistant starch might enhance early insulin response.
This was in normal-weight adults; consult a doctor if you have metabolic issues.
medium confidenceWhy this study matters
Belly Fat GONE: Resistant Starch Targets Visceral Fat
In a randomized crossover trial, 19 normal-weight adults ate 40g of resistant starch type 2 daily for 4 weeks. MRI scans revealed a significant drop in visceral fat area from 27.05 to 21.70 cm² (p<0.001) and a -10.88% change in subcutaneous fat, all without any change in overall body weight.
This shows that visceral fat—the dangerous fat around organs—can be reduced by diet alone, even in non-obese individuals, which is crucial for metabolic health.
The Insulin Boost: Better First-Phase Secretion
RS2 enhanced early-phase insulin and C-peptide secretion by ~22% at 30 minutes after a meal (insulin: 69.70 vs 56.98 μU/ml; C-peptide: 6.59 vs 5.72 ng/ml). This suggests improved β-cell responsiveness, potentially delaying type 2 diabetes onset.
Early insulin secretion is key for glucose control, and boosting it is a common target for diabetes prevention.
Gut Bacteria and Acetate: The Hidden Link
RS2 increased serum acetate and active GLP-1, with a positive correlation (r=0.46). It also increased gut bacteria like Ruminococcaceae_UCG-005 and trended towards more Akkermansia, while reducing Bacteroides and Blautia.
This reveals the microbiome's role in mediating metabolic benefits through short-chain fatty acids and GLP-1.
One Size Doesn't Fit All: Microbiome Personalization
Baseline gut microbiome predicted responses: high Streptococcus abundance was linked to greater hormone increases, while low Ruminococcus_torques_group, Eubacterium_hallii_group, and Eubacterium_eligens_group were associated with more fat loss.
This suggests that individuals may need tailored dietary advice based on their microbiome composition.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists wanted to see if eating a type of starch that isn't digested could reduce belly fat in healthy people. They gave some people this special starch and others a regular starch, and measured their belly fat with a scanner.
Research results
After 4 weeks of eating 40 grams of the special starch each day, the fat around the belly (especially the deep fat and fat under the skin) was reduced. It also increased some helpful hormones and changed the gut bacteria.
What this means - more context
This means that adding this special starch to your diet might help reduce belly fat, but it was tested in only 19 healthy adults, so more research is needed to see if it works for everyone.
To evaluate the effects of resistant starch type 2 (RS2) on body fat distribution, glucose metabolism, gut hormones, and gut microbiota in normal-weight adults using a controlled crossover design.
In a randomized, double-blind, crossover trial, 19 normal-weight adults received 40 g/day RS2 or energy-matched control starch for 4 weeks each. RS2 significantly reduced visceral and subcutaneous fat areas as measured by MRI, increased early-phase insulin and C-peptide secretion, elevated serum acetate and active GLP-1, reduced LDL-C and blood urea nitrogen, and altered gut microbiota composition, notably increasing Ruminococcaceae_UCG-005 and decreasing several genera including Bacteroides and Blautia.
Methods Used
Randomized, double-blind, crossover trial with 19 normal-weight adults (10 women, 9 men). Interventions: 40 g/day high-amylose RS2 or matched control starch for 4 weeks each, separated by a 4-week washout. Controlled diet provided to all subjects. Outcomes assessed: abdominal fat areas via MRI, glucose metabolism via meal tolerance test and hyperinsulinemic-euglycemic clamp, serum hormones (GLP-1, PYY, insulin, C-peptide), short-chain fatty acids, blood chemistry, and gut microbiota via 16S rRNA sequencing.
Main Finding
RS2 supplementation significantly reduced visceral and subcutaneous fat areas (visceral fat area from 27.05±2.67 to 21.70±1.78 cm², p<0.001; subcutaneous fat area decreased by -10.88%). RS2 also increased early-phase insulin (69.70 vs 56.98 μU/ml at 30 min, p<0.05), C-peptide (6.59 vs 5.72 ng/ml, p<0.01), active GLP-1 (p<0.05), and serum acetate (53.34 vs 38.79 μM, p<0.001), while reducing LDL-C (2.57 vs 2.73 mmol/l, p<0.05) and blood urea nitrogen (3.66 vs 4.10 mmol/l, p<0.05). Gut microbiota analysis showed increased Ruminococcaceae_UCG-005 and trends for Akkermansia, while multiple genera including Bacteroides and Blautia decreased.
Confidence Level
High confidence. The study is a well-designed randomized, double-blind, crossover trial with a controlled diet, objective MRI measurements, and detailed metabolomic and microbiome analyses. The sample size (19) is modest but appropriately powered for the primary outcome (visceral fat area). Results are plausible and consistent with mechanistic animal studies, though further validation in larger and more diverse populations is warranted.
Study Flags
Red Flags
- •Small sample size (19 participants)
- •Short duration (4 weeks per intervention)
- •Only normal-weight Chinese adults, limiting generalizability
Surprising Findings
Resistant starch reduced visceral fat in normal-weight adults, something not seen in obese/overweight populations in earlier studies.
Most research on RS for obesity has been in rodents or overweight humans. This is the first human trial to show a fat-reducing effect specifically in people at a healthy weight.
Practical Takeaways
Add resistant starch to your diet gradually. Good sources: cooked and cooled potatoes, green bananas, legumes, and raw oats. Aim for 15-30g/day initially.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 580 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Human RCT
Subject
High probability
on the GRADE evidence scale
这项研究就像一场公平的比赛，志愿者被随机分成两组，一组吃一种特别的淀粉，另一组吃普通淀粉，然后交换，大家不知道自己在哪组。结果发现这种淀粉确实可能让肚子上的脂肪减少，还能帮助身体分泌一些有用的激素。但参加的人很少，只有19个，所以我们要小心，不能肯定它对所有人都有效。
Strengths
- 随机化
- 双盲
- 交叉设计
Weaknesses
- 样本量小（19）
- 单一中心
- 短期干预（4周）
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists wanted to see if eating a type of starch that isn't digested could reduce belly fat in healthy people. They gave some people this special starch and others a regular starch, and measured their belly fat with a scanner.
Research results
After 4 weeks of eating 40 grams of the special starch each day, the fat around the belly (especially the deep fat and fat under the skin) was reduced. It also increased some helpful hormones and changed the gut bacteria.
What this means - more context
This means that adding this special starch to your diet might help reduce belly fat, but it was tested in only 19 healthy adults, so more research is needed to see if it works for everyone.
To evaluate the effects of resistant starch type 2 (RS2) on body fat distribution, glucose metabolism, gut hormones, and gut microbiota in normal-weight adults using a controlled crossover design.
In a randomized, double-blind, crossover trial, 19 normal-weight adults received 40 g/day RS2 or energy-matched control starch for 4 weeks each. RS2 significantly reduced visceral and subcutaneous fat areas as measured by MRI, increased early-phase insulin and C-peptide secretion, elevated serum acetate and active GLP-1, reduced LDL-C and blood urea nitrogen, and altered gut microbiota composition, notably increasing Ruminococcaceae_UCG-005 and decreasing several genera including Bacteroides and Blautia.
Methods Used
Randomized, double-blind, crossover trial with 19 normal-weight adults (10 women, 9 men). Interventions: 40 g/day high-amylose RS2 or matched control starch for 4 weeks each, separated by a 4-week washout. Controlled diet provided to all subjects. Outcomes assessed: abdominal fat areas via MRI, glucose metabolism via meal tolerance test and hyperinsulinemic-euglycemic clamp, serum hormones (GLP-1, PYY, insulin, C-peptide), short-chain fatty acids, blood chemistry, and gut microbiota via 16S rRNA sequencing.
Main Finding
RS2 supplementation significantly reduced visceral and subcutaneous fat areas (visceral fat area from 27.05±2.67 to 21.70±1.78 cm², p<0.001; subcutaneous fat area decreased by -10.88%). RS2 also increased early-phase insulin (69.70 vs 56.98 μU/ml at 30 min, p<0.05), C-peptide (6.59 vs 5.72 ng/ml, p<0.01), active GLP-1 (p<0.05), and serum acetate (53.34 vs 38.79 μM, p<0.001), while reducing LDL-C (2.57 vs 2.73 mmol/l, p<0.05) and blood urea nitrogen (3.66 vs 4.10 mmol/l, p<0.05). Gut microbiota analysis showed increased Ruminococcaceae_UCG-005 and trends for Akkermansia, while multiple genera including Bacteroides and Blautia decreased.
Confidence Level
High confidence. The study is a well-designed randomized, double-blind, crossover trial with a controlled diet, objective MRI measurements, and detailed metabolomic and microbiome analyses. The sample size (19) is modest but appropriately powered for the primary outcome (visceral fat area). Results are plausible and consistent with mechanistic animal studies, though further validation in larger and more diverse populations is warranted.
Study Flags
Red Flags
- •Small sample size (19 participants)
- •Short duration (4 weeks per intervention)
- •Only normal-weight Chinese adults, limiting generalizability
Surprising Findings
Resistant starch reduced visceral fat in normal-weight adults, something not seen in obese/overweight populations in earlier studies.
Most research on RS for obesity has been in rodents or overweight humans. This is the first human trial to show a fat-reducing effect specifically in people at a healthy weight.
Practical Takeaways
Add resistant starch to your diet gradually. Good sources: cooked and cooled potatoes, green bananas, legumes, and raw oats. Aim for 15-30g/day initially.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 580 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Human RCT
Subject
High probability
on the GRADE evidence scale
这项研究就像一场公平的比赛，志愿者被随机分成两组，一组吃一种特别的淀粉，另一组吃普通淀粉，然后交换，大家不知道自己在哪组。结果发现这种淀粉确实可能让肚子上的脂肪减少，还能帮助身体分泌一些有用的激素。但参加的人很少，只有19个，所以我们要小心，不能肯定它对所有人都有效。
Strengths
- 随机化
- 双盲
- 交叉设计
Weaknesses
- 样本量小（19）
- 单一中心
- 短期干预（4周）
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
这个研究做得挺仔细的，就像做实验时把其他条件都控制住，只改变我们要测试的东西。他们用双盲方法，大家都不知情，还交换着吃，这样结果更可靠。但因为人少，时间短，所以还不能说100%准确，但已经比很多研究要严谨了。
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
77 / 100
- Randomization+20/20
- Blinding+15/15
- Control group+15/15
- Sample size (n=19)+1.8/20
- Follow-up+10/10
100 / 100
100 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 580 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
This design can establish causation. 虽然该研究是随机双盲交叉试验，可以建立因果关系，但样本量较小（19名受试者）且为单一中心，结果可能不具有普遍性。此外，研究的持续时间较短（4周），长期效应未知。
COI Unknown
Could not determine conflict of interest status
No conflicts of interest information is provided in the available text.
Independent Analysis Safeguards
- Randomized double-blinded crossover design
- Controlled diet
The provided text does not include conflict of interest or funding declarations. The study is a randomized, double-blinded crossover trial with a controlled diet, which helps minimize bias. However, without additional information, it is impossible to assess potential conflicts of interest or funding sources.
Standing
Who’s using this study?
The videos and claims on this site that lean on this study, and the researchers who wrote it.
1 video from Physionic cite this study, drawing 1 claim from it.
- Conflicting evidence
Evidence points in both directions — no clear conclusion yet.
Evidence